Viking Therapeutics VKTX Return on invested capital

Return on invested capital at other companies

Eli LillyLLY

39.7%+10.3pp

PfizerPFE

6%—

AmgenAMGN

14.8%+3.6pp

Gyre Therapeutics, Inc.GYRE

-26.7%-32.7pp

Madrigal Pharmaceuticals, Inc.MDGL

-51.7%-2.9pp

VAN

Vivani MedicalVANI

-151.1%+81.7pp

FAQ

What is Viking Therapeutics's return on invested capital?

Viking Therapeutics (VKTX) reported return on invested capital of -59.2% in Q4 2025.

How has Viking Therapeutics's return on invested capital changed year-over-year?

Viking Therapeutics's return on invested capital decreased by 125.5% year-over-year, from -26.3% to -59.2%.

What is the long-term trend for Viking Therapeutics's return on invested capital?

Over 5 years (2020 to 2025), Viking Therapeutics's return on invested capital has grown at a 27.5% compound annual growth rate (CAGR), from -17.6% to -59.2%.

What does return on invested capital mean?

Net operating profit after tax (operating income taxed at the effective rate) divided by average invested capital (debt plus equity minus cash). Measures the after-tax return on all capital put to work in the business, independent of capital structure.